[Treatment with inorganic iodine for Graves' hyperthyroidism]

Area of Science:

• Endocrinology
• Internal Medicine

Background:

• Current Graves' hyperthyroidism treatment involves methimazole or propylthiouracil, which can cause serious adverse reactions like agranulocytosis.
• Inorganic iodine temporarily lowers thyroid hormone levels in Graves' disease without adverse effects.

Purpose of the Study:

• To evaluate the efficacy of inorganic iodine as a standalone therapy for mild Graves' hyperthyroidism.
• To explore the potential for long-term remission with inorganic iodine in specific patient subgroups.

Main Methods:

• Review of existing literature on inorganic iodine therapy for Graves' hyperthyroidism.
• Analysis of patient characteristics (thyroid volume, TRAb titers) associated with treatment response.

Main Results:

• Inorganic iodine therapy can induce a virtually complete remission or a longstanding euthyroid state in patients with mild Graves' disease.
• Patients with small thyroid volume and low thyrotropin receptor antibody (TRAb) titers are more likely to achieve remission.

Conclusions:

• Inorganic iodine therapy represents a promising treatment option for mild Graves' hyperthyroidism.
• This approach may offer a safer alternative to antithyroid drugs, particularly for carefully selected patients.